Bacterial co-infection and secondary infection in patients with Covid-19: a review

Abstract

Bacterial confections and secondary infections increase the severity of respiratory viral infections and were constant causes of mortality in influenza pandemics but have not been well characterized in patients with coronavirus disease 2019 (COVID-19). Streptococcus pneumoniae, Haemophilus influenzae, and Staphylococcus aureus are common microorganisms associated with co-infections. These co-infections are more common in severe cases and can have negative effects. However, due to symptoms that overlap with COVID-19, secondary infections, such as bacterial pneumonia, bronchitis, or sinusitis, can be difficult to diagnose. The complicated relationship between viral and bacterial infection affects how diseases grow, how they are diagnosed, and how they are treated. Different demographics, risk factors, and germs can cause differences in the number of people who get sick. Because symptoms often overlap, it's still hard to figure out the causative agent behind it. To close this knowledge gap, the goal of this review is to put together the most up-to-date information about bacterial- Co-infections and secondary infections in COVID-19 patients. It states more about Secondary and co-infections are feasible, but how frequently they happen depends on a number of variables, including a person's immune system, the pathogen's severity, and hygiene habits. Due to weakened immunity, people who have been infected may be more vulnerable to secondary infections, which could result in a more serious sickness or complications. The significant findings of this review paper emphasize that bacterial co-infections and secondary infections in COVID-19 patients, influenced by various factors, can significantly worsen disease outcomes, strain healthcare systems, and contribute to antibiotic resistance, highlighting the urgent need for improved diagnostics, personalized treatments, and comprehensive public health strategies.